- sales@expolake.com
- +1-469-567-9589
Access a verified, campaign-ready database of Alzheimer’s researchers, neurologists, dementia specialists, clinical investigators, healthcare executives, pharmaceutical leaders, biotech innovators, academic scientists, care professionals, and healthcare decision-makers attending and exhibiting at AAIC 2026 (Alzheimer’s Association International Conference). As the world’s largest forum for the dementia research community, AAIC brings together more than 11,000 attendees from across the global healthcare, research, and life sciences sectors.
Whether you are looking to schedule pre-event meetings, promote clinical research solutions, showcase healthcare technologies, recruit research partners, or expand your presence in the Alzheimer’s and dementia market, the ExpoLake AAIC 2026 contact list provides the accurate, segmented data your team needs to connect with the right professionals at the right time. AAIC covers key areas including basic and translational science, diagnosis and prognosis, imaging, therapeutics, prevention, public health, and dementia care research.
Verified Attendees
Exhibiting Companies
Accuracy
Delivery Time
Verification Layers
The Alzheimer’s Association International Conference (AAIC) 2026 is the world’s largest and most influential gathering dedicated to Alzheimer’s disease and dementia research. Taking place July 12–15, 2026 at Excel London, United Kingdom, and online, the conference brings together more than 11,000 researchers, clinicians, healthcare professionals, pharmaceutical leaders, and care experts from around the world to share the latest scientific discoveries and innovations in dementia care.
AAIC 2026 covers a broad range of topics including basic and translational science, diagnosis and prognosis, brain imaging, therapeutics, prevention strategies, public health, and dementia care research. The event serves as a global platform for presenting groundbreaking research, fostering collaborations, and advancing solutions aimed at improving the lives of individuals affected by Alzheimer’s disease and related dementias.
For organizations targeting healthcare, biotechnology, pharmaceuticals, clinical research, and aging services, AAIC 2026 offers direct access to one of the most concentrated audiences of dementia research and healthcare decision-makers anywhere in the world.
1350+ researchers, healthcare organizations, life sciences companies, and dementia-focused institutions participate in AAIC 2026, creating one of the largest gatherings dedicated to Alzheimer’s disease and dementia research worldwide.
Leading academic institutions, neuroscience research centers, memory clinics, and research networks presenting breakthrough discoveries in Alzheimer's disease, dementia prevention, diagnostics, and treatment development.
Global pharmaceutical manufacturers and biotechnology firms showcasing drug development programs, clinical-stage therapeutics, biomarkers, precision medicine solutions, and innovative approaches to neurodegenerative disease treatment.
Clinical research organizations, trial management providers, patient recruitment specialists, and research partners supporting Alzheimer's, dementia, and neuroscience clinical studies worldwide.
Companies offering advanced neuroimaging technologies, biomarker testing solutions, diagnostic platforms, genetic testing services, and early detection tools for Alzheimer's disease and related dementias.
Organizations delivering AI-powered healthcare solutions, cognitive assessment tools, digital health platforms, patient monitoring systems, real-world evidence analytics, and dementia care technologies.
Hospitals, healthcare systems, memory care providers, nonprofit organizations, patient advocacy groups, and aging services organizations focused on improving dementia care and patient outcomes.
Principal investigators, neuroscientists, research directors, laboratory scientists, and academic professionals leading studies in Alzheimer's disease, dementia prevention, biomarkers, genetics, and brain health research.
Neurologists, geriatricians, psychiatrists, memory care specialists, physicians, and healthcare practitioners involved in diagnosing, treating, and managing Alzheimer's disease and related dementias.
C-suite leaders, R&D executives, medical affairs directors, drug development teams, and biotechnology innovators responsible for advancing dementia therapeutics and clinical research programs.
Hospital executives, healthcare administrators, memory clinic directors, long-term care leaders, and healthcare decision-makers overseeing dementia care services and patient support programs.
Clinical trial managers, regulatory affairs specialists, study coordinators, CRO executives, patient recruitment experts, and compliance professionals supporting neuroscience and dementia research.
Care professionals, nonprofit leaders, patient advocacy organizations, public health researchers, caregivers, and community health specialists focused on improving dementia awareness, care delivery, and quality of life.
The AAIC 2026 contact database includes 20+ structured contact, firmographic, and organizational data fields built for precise segmentation and role-based targeting across Alzheimer’s research, dementia care, neuroscience, biotechnology, pharmaceutical, healthcare, and academic research organizations.
Each record provides insight into the individual contact, their professional responsibility, and the organization they represent, enabling highly targeted outreach beyond basic contact identifiers.
Core Data Fields in Our AAIC 2026 Attendees & Exhibitors List
Connect with verified Alzheimer's researchers, neurologists, neuroscientists, clinical investigators, healthcare executives, pharmaceutical leaders, biotech innovators, and dementia care professionals actively attending or exhibiting at AAIC 2026. Reach highly qualified healthcare and research decision-makers rather than generic healthcare contacts.
Every contact record undergoes rigorous validation through email verification, professional profile authentication, institutional cross-referencing, domain verification, and quality assurance checks. This process helps maximize deliverability, improve engagement rates, and minimize bounced outreach campaigns.
Use the AAIC 2026 contact database for email marketing, LinkedIn outreach, appointment scheduling, clinical trial recruitment, healthcare networking, research collaborations, product demonstrations, webinar promotions, and targeted post-event follow-up campaigns.
Each record includes verified job titles, research specialties, organization type, seniority level, company information, geographic location, and direct contact details, enabling highly personalized outreach to healthcare and scientific professionals.
Segment contacts by Alzheimer's research area, dementia specialty, institution type, therapeutic focus, clinical research involvement, geography, organization size, seniority level, and decision-making authority to reach your ideal audience.
Receive your AAIC 2026 database in Excel or CSV format, fully compatible with Salesforce, HubSpot, Microsoft Dynamics, Zoho CRM, Marketo, Pardot, and other leading CRM and marketing automation platforms. Fast delivery helps your team launch campaigns immediately.
Get verified attendee and exhibitor contact lists from past and upcoming event editions worldwide. ExpoLake delivers accurate, segmented B2B contact data covering key decision-makers and exhibiting companies, so your outreach always reaches the right person at the right time.
Before making your investment, request a complimentary preview of the ExpoLake AAIC 2026 database. This verified contact list covers attendees and exhibitors across Alzheimer’s research, dementia care, neuroscience, biotechnology, pharmaceuticals, healthcare organizations, and academic institutions, giving your team direct access to the professionals and decision-makers driving innovation in brain health and dementia science.
Every record is validated, segmented, and delivered ready for email marketing, LinkedIn outreach, appointment scheduling, clinical trial recruitment, partnership development, and healthcare networking campaigns. Explore the quality of our verified data before committing and see how the AAIC 2026 attendee and exhibitor database can support your business objectives.
Connect with verified Alzheimer's researchers, neurologists, dementia specialists, pharmaceutical executives, healthcare administrators, and clinical research leaders who influence research, treatment development, and healthcare purchasing decisions across the dementia ecosystem.
Get ahead of the competition by reaching AAIC 2026 attendees and exhibitors before the conference begins. Schedule meetings, introduce solutions, recruit research partners, and build awareness among key healthcare and scientific professionals.
AAIC attendees are highly engaged professionals actively seeking research collaborations, healthcare innovations, clinical technologies, diagnostics, therapeutics, and scientific partnerships, making them significantly more responsive than traditional cold outreach audiences.
Use the AAIC 2026 database to connect with organizations across Alzheimer's research, neuroscience, biotechnology, pharmaceuticals, healthcare systems, academic institutions, clinical research organizations, and aging services worldwide.
Continue conversations after the conference concludes. Use verified attendee and exhibitor data to nurture relationships, support business development efforts, schedule demonstrations, share research findings, and create long-term opportunities.
Every dollar invested in exhibiting, sponsorships, conference participation, and healthcare marketing becomes more valuable when paired with a targeted AAIC 2026 contact database. Pre-event and post-event outreach helps increase engagement and improve ROI.
Every contact in the ExpoLake database goes through a structured, multi-step sourcing and verification process before it reaches your team. Here is how we build data you can trust.
Contacts are gathered from trade shows, global directories, e-books, newsletters, and digital publications spanning dozens of industries and regions.
Machine learning fills missing fields, appends firmographic data, and segments contacts by industry, role, company size, and intent signals — automatically.
Every record is cross-checked against our master database and validated via social platforms, public registries, and news sources to confirm authenticity.
Anomalies, duplicates, and stale entries are flagged using statistical models and eliminated. A final manual audit ensures the highest standard of data quality.
A/B-tested opt-in email sequences are deployed to capture and confirm explicit consent, fully aligned with GDPR, CAN-SPAM, and CASL compliance frameworks.
A final tele-verification call confirms all data fields. Only fully validated, consented records are released to the client — clean, compliant, and ready to use.
AAIC attracts Alzheimer’s researchers, neuroscientists, clinicians, pharmaceutical companies, biotechnology innovators, healthcare providers, and dementia care professionals from around the world.
Yes. Contacts can be segmented by Alzheimer’s disease research, biomarkers, neuroscience, diagnostics, therapeutics, clinical trials, public health, and dementia care.
Universities, research institutes, hospitals, pharmaceutical companies, biotechnology firms, clinical research organizations, nonprofits, and healthcare technology providers.
Absolutely. The database can include CEOs, Chief Medical Officers, Research Directors, Medical Affairs Leaders, Principal Investigators, and senior healthcare executives.
Yes. Many organizations use the database to market healthcare technologies, clinical services, diagnostics, therapeutics, research platforms, and professional services.
Yes. AAIC welcomes thousands of attendees from healthcare, academia, research, and industry organizations across multiple countries worldwide.
Healthcare, pharmaceuticals, biotechnology, clinical research, neuroscience, diagnostics, medical devices, academic research, and aging services organizations.
